Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. (press release)
WARSAW, Ind., Dec. 4, 2014 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") announced today that it has proposed a remedy package to the European Commission (the "EC") to facilitate the EC's approval of Zimmer's proposed acquisition of Biomet (BMET).
Zimmer has been working closely with the EC to develop a mutually-acceptable solution to address the discrete concerns identified by the EC in its preliminary assessment of the proposed acquis...
